Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Acadia Healthcare ( (ACHC) ) just unveiled an update.
On January 20, 2026, Acadia Healthcare announced that Chief Executive Officer Christopher H. Hunter departed the company and resigned from its board, with the company expecting to enter into a separation and release agreement to be detailed in a later regulatory filing. That same day, the board reinstated former CEO and director Debra K. (Debbie) Osteen as chief executive, principal executive officer and Class I director, underscoring a leadership reset amid macro headwinds for healthcare providers while the board conducts a broader search for a long‑term successor and evaluates options to enhance shareholder value. Osteen, a long-time industry leader credited with helping build Acadia into a leading behavioral health provider, has entered into a new open‑ended employment agreement that includes a $1.061 million base salary, performance-based annual bonus eligibility and a sizeable stock option grant tied to multi-year share price targets and retention conditions, aligning her compensation with company performance. Acadia reaffirmed its full-year 2025 financial guidance, maintaining revenue expectations of $3.28 billion to $3.30 billion, adjusted EBITDA of $601 million to $611 million, and adjusted EPS of $1.94 to $2.04, signaling operational stability and continuity of its growth strategy despite the leadership transition.
The most recent analyst rating on (ACHC) stock is a Hold with a $12.50 price target. To see the full list of analyst forecasts on Acadia Healthcare stock, see the ACHC Stock Forecast page.
Spark’s Take on ACHC Stock
According to Spark, TipRanks’ AI Analyst, ACHC is a Neutral.
The score is held back primarily by weak technicals (price below key moving averages and negative MACD). Financial performance is mixed: strong revenue growth and improved gross margin are offset by declining profitability, higher leverage, and weak cash conversion. Valuation is supportive with a modest P/E, while the latest earnings call was mixed due to reduced EBITDA guidance despite ongoing growth and operational initiatives.
To see Spark’s full report on ACHC stock, click here.
More about Acadia Healthcare
Acadia Healthcare is a leading U.S. provider of behavioral healthcare services, operating 278 facilities with approximately 12,500 beds across 40 states and Puerto Rico as of September 30, 2025. The company focuses on inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics, serving more than 82,000 patients daily and positioning itself as the largest stand-alone behavioral healthcare company in the country.
Average Trading Volume: 2,902,164
Technical Sentiment Signal: Sell
Current Market Cap: $1.08B
For a thorough assessment of ACHC stock, go to TipRanks’ Stock Analysis page.